Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 2 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
New study helps explain how elderly individuals react differently to COVID-19 than young people
Medical Xpress· 6 days agoThe COVID-19 pandemic resulted in over 700 million infections and 7 million deaths worldwide. While age is recognized as a risk factor for severe COVID-19, the reasons for this are not yet fully understood.
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo Finance· 3 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced...
Xencor (NASDAQ:XNCR) Price Target Cut to $40.00 by Analysts at Raymond James
ETF DAILY NEWS· 2 days agoXencor (NASDAQ:XNCR – Free Report) had its target price lowered by Raymond James from $58.00 to $40.00 in a research report report published on Friday, Benzinga reports. The firm currently has ...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - Indianapolis Business Journal
Indianapolis Business Journal· 7 days agoModerna’s combination shot generated higher immune responses against the influenza virus and SARS-...
Another COVID vaccine? Yes, and here’s why
San Jose Mercury News· 5 days agoThis fall, prepare for the latest round of COVID vaccine Whac-a-Mole. Protection against both infection and severe illness is waning. “Effectiveness has...
Summer surge? South Bay health officials keep close eye on COVID-19 concentrations
NBC Bay Area· 4 days agoThe Santa Clara County Public Health Department said it is seeing the start of what may be a summer...
What causes long COVID? Case builds for rogue antibodies
Nature· 4 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
Hologic, Inc. (NASDAQ:HOLX) Shares Sold by Northern Trust Corp
ETF DAILY NEWS· 7 days agoNorthern Trust Corp reduced its holdings in Hologic, Inc. (NASDAQ:HOLX – Free Report) by 6.9% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,708,357 shares ...
Moderna says new-generation COVID vaccine more effective than Spikevax
Market Watch· 3 days ago“Today’s vaccine efficacy data are consistent with the previously announced immunogenicity results...